TickerSpark Feed

biotech

Everything tagged "biotech" across research, earnings, and macro.

2 articles

Thermo Fisher Scientific (TMO): Quality Franchise, Price Debate

Thermo Fisher Scientific remains a top-tier life sciences platform with recurring revenue, strong cash flow, and multiple growth catalysts. The stock is a Buy, but the report argues the main question is valuation rather than business quality.

Apr 23, 2026·28 min read

Healthcare Diagnostics & Research Life Sciences

Research ReportSMMT

Summit Therapeutics (SMMT): Ivonescimab’s High-Stakes FDA Catalyst

Summit Therapeutics is a high-upside, high-volatility oncology story centered on ivonescimab and a November 2026 FDA decision. The clinical data are compelling, but the stock already prices in a lot of success.

Apr 22, 2026·26 min read

Healthcare Biotechnology Biotech

Want AI Research on Any Stock?

Generate a deep-dive report on any ticker. AI analyst, daily market intelligence, portfolio tools.

Get Full Access